EP3240791

PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    29.12.2015
  • EP published:
    6.11.2019
  • EP application number:
    15832772.6
  • Max expiry date:
    28.12.2035
  • Title:
    PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS

Timeline

Today
29.12.2015EP application
6.11.2019EP Publication

Owner

  • Name:
    Forma Therapeutics, Inc.
  • Address:
    500 Arsenal St., Suite 100, 02472, Watertown, MA, US

Inventor

  • Name:
    IOANNIDIS, Stephanos
  • Address:
    Natick, Massachusetts, US
  • Name:
    TALBOT, Adam Charles
  • Address:
    Guilford, Connecticut, US
  • Name:
    FOLLOWS, Bruce
  • Address:
    Littleton, Massachusetts, US
  • Name:
    BUCKMELTER, Alexandre Joseph
  • Address:
    Acton, Massachusetts, US
  • Name:
    WANG, Minghua
  • Address:
    Acton, Massachusetts, US
  • Name:
    CAMPBELL, Ann-Marie
  • Address:
    Monroe, Connecticut, US
  • Name:
    SCHMIDT, Darby Rye
  • Address:
    Arlington, Massachusetts, US
  • Name:
    GUERIN, David Joseph
  • Address:
    Natick, Massachusetts, US
  • Name:
    CARAVELLA, Justin A.
  • Address:
    Cambridge, Massachusetts, US
  • Name:
    DIEBOLD, R. Bruce
  • Address:
    Waltham, Massachusetts, US
  • Name:
    ERICSSON, Anna
  • Address:
    Shrewsbury, Massachusetts, US
  • Name:
    LANCIA, David R., Jr.
  • Address:
    Boston, Massachusetts, US

Priority

  • Number:
    201462098141 P
  • Date:
    30.12.2014
  • Country:
    US

Classification

  • Categories:
    C07D 487/04, A61K 31/519

Upload documents